Lanadelumab prophylaxis reduces breakthrough hereditary angioedema attacks and the need for rescue medication: Exploratory findings from the phase 3 HELP study

被引：0

作者：

Cicardi, M. ^{[1
]}

Maurer, M. ^{[2
]}

Longhurst, H. J. ^{[3
]}

Johnston, D. T. ^{[4
]}

Li, H. H. ^{[5
]}

Nurse, C. ^{[6
]}

Lu, P. ^{[6
]}

Busse, P. J. ^{[7
]}

机构：

[1] Univ Milan, Luigi Sacco Hosp, Dept Biomed & Clin Sci, ASST Fatebenefratelli Sacco, Milan, Italy

[2] Charite Univ Med Berlin, Charite, Allergie Ctr, Dept Dermatol & Allergy, Berlin, Germany

[3] Cambridge Univ Hosp NHS Fdn Trust, Addenbrooke s Hosp, Cambridge, England

[4] Clin Res Charlotte, Charlotte, NC USA

[5] Inst Asthma & Allergy PC, Chevy Chase, MD USA

[6] Takeda, Lexington, MA USA

[7] Icahn Sch Med Mt Sinai, Div Allergy & Clin Immunol, New York, NY 10029 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

PD0374

引用

页码：212 / 212

页数：1